Sphera Funds Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-200,000
Closed -$29.6M 124
2020
Q3
$29.6M Buy
+200,000
New +$31M 2.91% 7

Other funds holding LLY

Sphera Funds Management's LLY Position: Q2 2026 in Review

Sphera Funds Management reduced its Eli Lilly (LLY) stake by 11% in Q2 2026, selling an estimated $1.02M and leaving 8,040 shares worth $9.64M. The position accounts for 1.26% of the portfolio, ranked #19.

Sphera Funds Management first reported a position in LLY in Q1 2014 and has held it in 31 quarters since. The position peaked at $80.5M in Q3 2021. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Sphera Funds Management held 8,040 shares of Eli Lilly worth $9.64M as of Q2 2026.
  • Sphera Funds Management sold 1,000 Eli Lilly shares in Q2 2026, an estimated $1.02M.
  • Eli Lilly made up 1.26% of Sphera Funds Management's portfolio in Q2 2026, its #19 holding.
  • Sphera Funds Management first reported a position in Eli Lilly in Q1 2014 and has held it in 31 quarters since.
  • Sphera Funds Management's Eli Lilly position peaked at $80.5M in Q3 2021.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.